Literature DB >> 9819897

The characterisation of three substituted zinc phthalocyanines of differing charge for use in photodynamic therapy. A comparative study of their aggregation and photosensitising ability in relation to mTHPC and polyhaematoporphyrin.

D J Ball1, S R Wood, D I Vernon, J Griffiths, T M Dubbelman, S B Brown.   

Abstract

Three substituted zinc (II) phthalocyanines (one anionic, one cationic and one hydrophobic) have been compared to two clinically used photosensitisers, 5,10,15,20-tetra (m-hydroxyphenyl) chlorin (mTHPC) and polyhaematoporphyrin (PHP), as potential agents for photodynamic therapy (PDT). Oxygen-consumption experiments, performed to follow the photo-oxidation of tryptophan, histidine and bovine serum albumin (BSA), suggest that the anionic phthalocyanine is the most efficient photosensitiser. The efficacy of BSA oxidation is much greater than that of tryptophan or histidine, which is partly due to monomerisation of the sensitisers upon binding to BSA. Spectra recorded in aqueous solution reveal that all five compounds are highly aggregated, but monomerisation is induced upon the addition of BSA or methanol. Using a range of methanol-buffer solutions, the aggregation state has been directly related to the efficacy of tryptophan photo-oxidation with maximal rates of oxidation achieved when the sensitiser is monomeric. Using erythrocytes as a simple membrane model, the efficacy of each sensitiser exhibits a different trend from that predicted by oxygen-consumption experiments. The anionic phthalocyanine is the least effective at photohaemolysis, whereas the cationic and hydrophobic phthalocyanines have improved activity over PHP and mTHPC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819897     DOI: 10.1016/S1011-1344(98)00156-0

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  6 in total

1.  Pentalysine beta-carbonylphthalocyanine zinc: an effective tumor-targeting photosensitizer for photodynamic therapy.

Authors:  Zhuo Chen; Shanyong Zhou; Jincan Chen; Yicai Deng; Zhipu Luo; Hongwei Chen; Michael R Hamblin; Mingdong Huang
Journal:  ChemMedChem       Date:  2010-06-07       Impact factor: 3.466

2.  Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics.

Authors:  Leanne B Josefsen; Ross W Boyle
Journal:  Theranostics       Date:  2012-10-04       Impact factor: 11.556

3.  Encapsulation of Hydrophobic Phthalocyanine with Poly(N-isopropylacrylamide)/Lipid Composite Microspheres for Thermo-Responsive Release and Photodynamic Therapy.

Authors:  Jiaojiao Liu; Jingliang Li; Zexin Zhang; Yuyan Weng; Gaojian Chen; Bing Yuan; Kai Yang; Yuqiang Ma
Journal:  Materials (Basel)       Date:  2014-04-30       Impact factor: 3.623

4.  Synthesis and Spectroscopic and Luminescent Properties of Er, Yb and Lu Complexes with Cyano-Substituted Phthalocyanine Ligands.

Authors:  Dmitrii Erzunov; Ilya Sarvin; Anastasia Belikova; Arthur Vashurin
Journal:  Molecules       Date:  2022-06-23       Impact factor: 4.927

5.  Photodynamic therapy and the development of metal-based photosensitisers.

Authors:  Leanne B Josefsen; Ross W Boyle
Journal:  Met Based Drugs       Date:  2008

Review 6.  Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer Phototherapy.

Authors:  Lucimara R Carobeli; Lyvia E de F Meirelles; Gabrielle M Z F Damke; Edilson Damke; Maria V F de Souza; Natália L Mari; Kayane H Mashiba; Cristiane S Shinobu-Mesquita; Raquel P Souza; Vânia R S da Silva; Renato S Gonçalves; Wilker Caetano; Márcia E L Consolaro
Journal:  Pharmaceutics       Date:  2021-12-02       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.